Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia.

Humans Hematopoietic Stem Cell Transplantation / adverse effects Leukemia, Myeloid, Acute / therapy Stem Cell Transplantation Core Binding Factors / genetics Retrospective Studies

Journal

American journal of hematology
ISSN: 1096-8652
Titre abrégé: Am J Hematol
Pays: United States
ID NLM: 7610369

Informations de publication

Date de publication:
12 2023
Historique:
revised: 28 07 2023
received: 26 05 2023
accepted: 29 08 2023
medline: 16 11 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

A swimmer plot on clinical course of patients undergoing allogeneic stem cell transplant for core binding factor acute myeloid leukemia.

Identifiants

DOI: 10.1002/ajh.27092 PMID: 37705256
pubmed: 37705256
doi: 10.1002/ajh.27092
doi:

Substances chimiques

Core Binding Factors 0

Types de publication

Letter Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

E360-E363

Commentaires et corrections

Type : CommentOn

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Senapati J, Abuasab T, Haddad FG, et al. Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. Am J Hematol. 2023;98:E53-E56. doi:10.1002/ajh.26811
Borthakur G, Kantarjian H. Core binding factor acute myelogenous leukemia-2021 treatment algorithm. Blood Cancer J. 2021;11:114. doi:10.1038/s41408-021-00503-6
Hills RK, Castaigne S, Appelbaum FR, et al. Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials. Lancet Oncol. 2014;15:986-996.
Döhner H, Wei AH, Appelbaum FR, et al. Bob Löwenberg; diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345-1377. doi:10.1182/blood.2022016867
Jahn N, Terzer T, Sträng E, et al. Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication. Blood Advances. 2020;4(24):6342-6352. doi:10.1182/bloodadvances.2020002673
Puckrin R, Atenafu EG, Claudio JO, et al. Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia. Haematologica. 2021;106:56-63. doi:10.3324/haematol.2019.235721

Auteurs

Parth C Patel (PC)

Department of Internal Medicine, University of South Florida, Tampa, Florida, USA.
ORCID: 0000-0002-8528-1029

Somedeb Ball (S)

Division of Hematology and Medical Oncology, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Akriti G Jain (AG)

Division of Hematology and Medical Oncology, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0002-7238-9241

Chen Wang (C)

Department of Internal Medicine, University of South Florida, Tampa, Florida, USA.
ORCID: 0000-0003-4055-7391

Mohammad O Hussaini (MO)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0001-5192-0489

Luis E Aguirre (LE)

Division of Hematology and Medical Oncology, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Onyee Chan (O)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0003-2872-1961

Seongseok Yun (S)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Andrew Kuykendall (A)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0002-9040-7415

Eric Padron (E)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Kendra Sweet (K)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0001-6248-3317

Jeffrey E Lancet (JE)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0002-7751-7310

Rami S Komrokji (RS)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0002-1876-5269

David A Sallman (DA)

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
ORCID: 0000-0003-0504-8233

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Drivers of deep molecular response and...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Drivers of deep molecular response and...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Leucémies › Leucémie myéloïde › Leucémie aigüe myéloïde › Drivers of deep molecular response and...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Drivers of deep molecular response and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription CBF › Drivers of deep molecular response and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Drivers of deep molecular response and...